0001144204-18-045023.txt : 20180815 0001144204-18-045023.hdr.sgml : 20180815 20180815211113 ACCESSION NUMBER: 0001144204-18-045023 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180813 FILED AS OF DATE: 20180815 DATE AS OF CHANGE: 20180815 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BENDHEIM JACK CENTRAL INDEX KEY: 0001241560 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36410 FILM NUMBER: 181022191 MAIL ADDRESS: STREET 1: C/O EMPIRE RESOURCES, INC. STREET 2: 1 PARKER PLAZA, SUIET 10 CITY: FORT LEE STATE: NJ ZIP: 07024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHIBRO ANIMAL HEALTH CORP CENTRAL INDEX KEY: 0001069899 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 131840497 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 BUSINESS PHONE: 201-329-7300 MAIL ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 FORMER COMPANY: FORMER CONFORMED NAME: PHILIPP BROTHERS CHEMICALS INC DATE OF NAME CHANGE: 19980908 4 1 tv501072_4.xml OWNERSHIP DOCUMENT X0306 4 2018-08-13 0 0001069899 PHIBRO ANIMAL HEALTH CORP PAHC 0001241560 BENDHEIM JACK 300 FRANK W. BURR BLVD., STE 21 TEANECK NJ 07666 1 1 1 0 President and CEO Class A Common Stock 2018-08-13 4 C 0 60000 0 A 60000 I See Class A Common Stock 2018-08-13 4 S 0 10000 50.03 D 50000 I See Class A Common Stock 2018-08-14 4 S 0 10000 49.90 D 40000 I See Class A Common Stock 2018-08-15 4 S 0 10000 49.33 D 30000 I See Class B Common Stock 0 2018-08-13 4 C 0 60000 0 D Class A Common Stock 60000 20246034 I See Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis and has no expiration date. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2017. The securities are held by BFI Co., LLC. Mr. Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFICo., LLC and may be deemed to have shared voting and investment power over the securities held by BFI Co., LLC. Mr. Bendheim disclaims beneficialownership of these securities except to the extent of his pecuniary interest therein. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.90 to $50.85, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.60 to $50.20, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.00 to $49.75, inclusive. /s/ Thomas G. Dagger, as Attorney-in-Fact for Jack Bendheim 2018-08-15